Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same

Details for Australian Patent Application No. 2008315951 (hide)

Owner Sanofi-Aventis

Inventors Struebing, Carsten; Miehe, Susanne

Agent Watermark

Pub. Number AU-A-2008315951

PCT Pub. Number WO2009/052971

Priority 07291300.7 26.10.07 EP

Filing date 14 October 2008

Wipo publication date 30 April 2009

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052971 Priority application(s): WO2009/052971

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008315952-Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels

2008315950-Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors